Waverly Advisors LLC Boosts Holdings in iShares Biotechnology ETF $IBB

Waverly Advisors LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 128.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,515 shares of the financial services provider’s stock after acquiring an additional 29,544 shares during the period. Waverly Advisors LLC owned about 0.10% of iShares Biotechnology ETF worth $9,988,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $201,000. AQR Capital Management LLC bought a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth about $455,000. Millennium Management LLC increased its stake in iShares Biotechnology ETF by 140.8% during the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after acquiring an additional 143,893 shares during the last quarter. M&T Bank Corp raised its holdings in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock valued at $337,000 after buying an additional 750 shares during the period. Finally, Walleye Capital LLC raised its stake in shares of iShares Biotechnology ETF by 26.8% in the second quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock valued at $589,000 after acquiring an additional 985 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $205.49 on Thursday. The business has a 50 day simple moving average of $199.14 and a two-hundred day simple moving average of $181.02. iShares Biotechnology ETF has a 1 year low of $138.79 and a 1 year high of $217.12.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a $0.0238 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.0%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.